SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Morgan Stanley Maintains Equal-Weight on Immunomedics, Raises Price Target to $32

Morgan Stanley maintains Immunomedics (NASDAQ:IMMU) with a Equal-Weight and raises the price target from $22 to $32.

Benzinga · 05/07/2020 12:36

Morgan Stanley maintains Immunomedics (NASDAQ:IMMU) with a Equal-Weight and raises the price target from $22 to $32.